Deutsch English Français

Contact

EP1961820

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1961820

EP1961820 - Vaccine composition comprising LAGE-1 tumor associated nucleic acids or LAGE-1 polypeptides [Right-click to bookmark this link]
Former [2008/35]	Lage-1 tumor associated nucleic acids
	[2012/17]
Status	No opposition filed within time limit Status updated on 04.10.2013 Database last updated on 31.08.2024
Most recent event Tooltip	17.07.2015	Lapse of the patent in a contracting state New state(s): LU	published on 19.08.2015 [2015/34]
Applicant(s)	For all designated states Ludwig Institute for Cancer Research Ltd 666 Third Avenue, 28th Floor New York, NY 10017 / US
	[2012/48]
Former [2008/35]	For all designated states LUDWIG INSTITUTE FOR CANCER RESEARCH 605 Third Avenue New York New York 10158 / US
Inventor(s)	01 / Lethe, Bernard Institute Ludwig pour la Rechercher sue le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE
	02 / Lucas, Sophie Institute Ludwig pour la Recherche sur le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE
	03 / de Smet, Charles Institute Ludwig pour la Recherche sur le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE
	04 / Godelaine, Daniele Institute Ludwig pour la Recherche sur le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE
	05 / Boon-Falleur, Thierry Institute Ludwig pour la Recherche sur le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE
	[2012/48]
Former [2008/35]	01 / Lethe, Bernard Institute Ludwig pour la Rechercher sue le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE
	02 / Lucas, Sophie Institute Ludwig pour la Recherche sur le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE
	03 / de Smet, Charles Institute Ludwig pour la Recherche sur le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE
	04 / Godelaine, Daniele Institute Ludwig pour la Recherche sur le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE
	05 / Boon-Falleur, Thierry Institute Ludwig pour la Recherche sur le Cancer Avenue Hippocrate 74 UCL 7459 1200 Brussels / BE
Representative(s)	Gill, Siân Victoria, et al Venner Shipley LLP 200 Aldersgate London EC1A 4HD / GB
	[2013/30]
Former [2008/35]	Furlong, Isla Jane, et al Venner Shipley LLP Byron House Cambridge Business Park Cowley Road Cambridge CB4 0WZ / GB
Application number, filing date	08154900.8	27.01.1998
	[2008/35]
Priority number, date	US19970791495	27.01.1997 Original published format: US 791495
	[2008/35]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	EP1961820
	Date:	27.08.2008
	Language:	EN
	[2008/35]
	Type:	A3 Search report
	No.:	EP1961820
	Date:	24.12.2008
	[2008/52]
	Type:	B1 Patent specification
	No.:	EP1961820
	Date:	28.11.2012
	Language:	EN
	[2012/48]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	26.11.2008
Classification	IPC:	A61K39/00, C07K14/705, C07K14/47	[2012/17]
	CPC:	C07K14/70539 (EP); C07K14/4748 (EP); A61K2039/51 (EP); A61K38/00 (EP); A61K39/00 (EP)
	Former IPC [2008/35]	C12N15/12, C07K14/705, C07K16/18, C12Q1/68, A61K38/17, // C12N15/11, A61K48/00
Designated contracting states	AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2008/35]
Title	German:	Impfstoffzusammensetzung welche LAGE-1-Tumor-assoziierte Nukleinsäuren oder LAGE-1 Polypeptide enthält	[2012/17]
	English:	Vaccine composition comprising LAGE-1 tumor associated nucleic acids or LAGE-1 polypeptides	[2012/17]
	French:	Composition vaccinale comprenant des acides nucléiques LAGE-1 associés aux tumeurs ou des polypeptides LAGE-1	[2012/17]
	Former [2008/35]	LAGE-1-Tumor-assoziierte Nukleinsäuren
	Former [2008/35]	Lage-1 tumor associated nucleic acids
	Former [2008/35]	Acides nucléiques associés à la tumeur LAG-1
Examination procedure	04.03.2009	Amendment by applicant (claims and/or description)
	26.05.2009	Examination requested [2009/27]
	10.06.2010	Despatch of a communication from the examining division (Time limit: M06)
	20.12.2010	Reply to a communication from the examining division
	19.04.2012	Communication of intention to grant the patent
	08.08.2012	Fee for grant paid
	08.08.2012	Fee for publishing/printing paid
Parent application(s) Tooltip	EP98903726.2 / EP0970206
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP19980903726) is 29.01.2002
Opposition(s)	29.08.2013	No opposition filed within time limit [2013/45]
Fees paid	Renewal fee
	21.04.2008	Renewal fee patent year 03
	21.04.2008	Renewal fee patent year 04
	21.04.2008	Renewal fee patent year 05
	21.04.2008	Renewal fee patent year 06
	21.04.2008	Renewal fee patent year 07
	21.04.2008	Renewal fee patent year 08
	21.04.2008	Renewal fee patent year 09
	21.04.2008	Renewal fee patent year 10
	21.04.2008	Renewal fee patent year 11
	20.01.2009	Renewal fee patent year 12
	19.01.2010	Renewal fee patent year 13
	28.01.2011	Renewal fee patent year 14
	30.01.2012	Renewal fee patent year 15
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	DK	28.11.2012
	FI	28.11.2012
	IT	28.11.2012
	SE	28.11.2012
	LU	27.01.2013
	MC	31.01.2013
	GR	01.03.2013
	ES	11.03.2013
	PT	28.03.2013
	DE	01.08.2013
	[2015/34]
Former [2013/48]	DK	28.11.2012
	FI	28.11.2012
	IT	28.11.2012
	SE	28.11.2012
	MC	31.01.2013
	GR	01.03.2013
	ES	11.03.2013
	PT	28.03.2013
	DE	01.08.2013
Former [2013/37]	DK	28.11.2012
	FI	28.11.2012
	IT	28.11.2012
	SE	28.11.2012
	MC	31.01.2013
	GR	01.03.2013
	ES	11.03.2013
	PT	28.03.2013
Former [2013/34]	DK	28.11.2012
	FI	28.11.2012
	SE	28.11.2012
	GR	01.03.2013
	ES	11.03.2013
	PT	28.03.2013
Former [2013/28]	FI	28.11.2012
	SE	28.11.2012
	GR	01.03.2013
	ES	11.03.2013
	PT	28.03.2013
Former [2013/24]	FI	28.11.2012
	SE	28.11.2012
	GR	01.03.2013
	ES	11.03.2013
Former [2013/22]	FI	28.11.2012
	SE	28.11.2012
	ES	11.03.2013
Former [2013/21]	SE	28.11.2012
Documents cited:	Search	[DA]WO9220356 (LUDWIG INST CANCER RES [US]);
		[E]WO9814464 (LUDWIG INST CANCER RES [US]);
	by applicant	WO9204381
		WO9220356
		US5342774
		WO9500654
		US5399346
		US5405940
		WO9610577
		US5571711
		US5587289
		US5589334
		US5610013
		US5620886
		US5683886
		US5804381
		US5821122
		US5939526
		US5997870
		US19920994928
		US19930008446
		US19930096039
		US19950408015
		US19950530015

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p